Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![HighSell53466 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1937749820602753024.png) Buy High Sell Low [@HighSell53466](/creator/twitter/HighSell53466) on x XXX followers
Created: 2025-07-21 15:23:06 UTC

$VKTX oral obesity drug could rewrite the GLP-1 narrative.
While $LLY and $NVO dominate injectables, oral convenience is the next frontier.
If Viking nails efficacy, it won’t just compete — it could expand the market.


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947316410272629080/c:line.svg)

**Related Topics**
[$lly](/topic/$lly)
[$vktx](/topic/$vktx)
[eli lilly](/topic/eli-lilly)
[stocks healthcare](/topic/stocks-healthcare)
[$nvo](/topic/$nvo)
[$vik](/topic/$vik)

[Post Link](https://x.com/HighSell53466/status/1947316410272629080)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

HighSell53466 Avatar Buy High Sell Low @HighSell53466 on x XXX followers Created: 2025-07-21 15:23:06 UTC

$VKTX oral obesity drug could rewrite the GLP-1 narrative. While $LLY and $NVO dominate injectables, oral convenience is the next frontier. If Viking nails efficacy, it won’t just compete — it could expand the market.

XXXXX engagements

Engagements Line Chart

Related Topics $lly $vktx eli lilly stocks healthcare $nvo $vik

Post Link

post/tweet::1947316410272629080
/post/tweet::1947316410272629080